Efficacy and Safety Study of Squalamine Ophthalmic Solution in Subjects With Neovascular AMD
Clinical trial NCT02727881 · UNKNOWN
Trial details
- NCT number
- NCT02727881
- Sponsor
- Ohr Pharmaceutical Inc.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-12
- Primary completion
- 2017-12-01
- Enrollment
- 230
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.